主治医の祈り ～男子性腺機能低下症～

出版社： メディカルレビュー社
著者：
発行日： 2023-11-20
分野： 臨床医学：外科  >  泌尿器科学
ISBN： 9784779226700
電子書籍版： 2023-11-20 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

購入する

商品紹介

50年以上にわたり、幅広く多種多様な内分泌疾患を診てきた専門医が、男子性腺機能低下症に焦点を当て、これまでの取り組みを伝える。2020年10月の教育講演をもとに書籍化。

目次

  • Chapter1　男子性腺の発生と分化から完成まで

    Chapter2　男性におけるテストステロンの働き
    　Column 患者さんと歩む
    　　主治医のノート(1)
    　　主治医のノート(2)
    　　主治医のノート(3)
    　　主治医のノート(4)
    　Essay テストステロンはいったい何者か？

    Chapter3　発症年齢からみた男子の性腺機能低下症
    　Column 患者さんと歩む
    　　患者さんの思い【1】
    　Essay mini-puberty の洗礼

    Chapter4　男性の性腺機能低下症の病因と分類および治療概論

    Chapter5　カルマン症候群
    　Column 患者さんと歩む
    　　主治医のノート(5)
    　　患者さんの思い【2】
    　　患者さんの思い【3】
    　　患者さんの思い【4】
    　　患者さんの思い【5】
    　Essay 男らしさ（masculinity）のトリガー
    　Essay 性腺機能低下症と嗅覚欠損の関係性をフェロモンから読み解く

    Chapter6　脳腫瘍術後の性腺機能低下症

    Chapter7　クラインフェルター症候群
    　Column 患者さんと歩む　
    　　患者さんの思い【6】
    　　患者さんの思い【7】
    　　患者さんの思い【8】

    Chapter8　加齢男性性腺機能低下症候群（ＬＯＨ症候群）
    　Essay 性別不合（かつての性同一性障害）
    　Column 患者さんと歩む
    　　患者さんの思い【9】

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

文献

P.214 掲載の参考文献
1) Christopher Ryan, Cacilda Jetha. Sex at Dawn. 山本規雄 訳 : 性の進化論. 作品社, 2014.
 
2) 長谷川寿一, 長谷川真理子. 進化と人間行動. 東京大学出版会, 2000.
 
3) 長谷川真理子. オスとメス=性の不思議. 講談社現代新書, 1993.
 
4) Sekido R, Lovell-Badge R. Sex determination and SRY : down to a wink and a nudge? Trends Genet 25 : 19-29, 2009.
 
5) Veldhuis JD, King JC, Urvan RJ, et al. Operative characteristics of the male hypothalamo-pituitary-gonadal axis : pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 65 : 929-941, 1987.
 
6) Biason-Lauber A. Control of sex development. Best Pract Res Clin Endocrinol Metab 24 : 163-186, 2010.
PubMed
7) Tapanainen J, Kellokumpu-Lehtinen P, Pellineimi L, Huhutaniemi I. Age-related changes in endogenous steroids of human fetal testis during early and midpregnancy. J Clin Endocrinol Metab 52 : 98-102, 1981.
 
8) Miller WL : Molecular biology of steroid hormone synthesis. Endocr Rev 9 : 295-318, 1988.
PubMed
9) Payne AH, Hales DB. Overview of steroidogenic enzyme in the pathway from cholesterol to active steroid hormones. Endocr Rev 25 : 947-970, 2004.
PubMed
10) Rey RA, Grinspon RP. Normal male sexual differentiation and aetiology of disorders of sex development. Best Pract Res Clin Endocrinol Metab 25 : 221-238, 2011.
PubMed
11) Nielsen CT, Skakkebaek NE, Richardson DW, et al. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab 62 : 532-535, 1986.
 
12) Kauffman AS, Smith JT. Kisspeptin signaling in Reproductive Biology. Springer, 2013.
 
13) Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update 20 : 485-500, 2014.
PubMed
14) Boyar RM, Rosenfeld RS, Kapen S, et al. Human puberty. Simultaneous augmented secretion of luteinizing hormone and testosterone during sleep. J Clin Invest 54 : 609-618, 1974.
 
15) Patton GC, Viner R. Pubertal transitions in health. Lancet 369 : 1130-1139, 2007.
PubMed
16) Oakley AE, Clifton DK, Steiner RA. Kisspeptin signaling in the brain. Endocr Rev 30 : 713-743, 2009.
PubMed
17) Horikoshi Y, Matsumoto H,Takatsu Y, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy : metastin as a novel placentaderived hormone in humans. J Clin Endocrinol Metab 88 : 914-919, 2003.
PubMed
18) Kotani M, Katagiri F, Hirai T, et al. Plasma kisspeptin levels in male cases with hypogonadism. Endocr J 61 : 1137-1140, 2014.
PubMed
19) Katagiri F, Kotani M, Hirai T, et al. The relationship between circulating kisspeptin and sexual hormones levels in healthy females. Biochem Biophys Res Commun 458 : 663-666, 2015.
PubMed
20) Kotani M, Katagiri F, Hirai T, et al. Plasma kisspeptin levels in lactational amenorrhea. Gynecol Endocrinol 33 : 819-821, 2017.
PubMed
21) Finkelstein JS, Lee H, Burnett-Bowie SA, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl JMed 369 : 1011-1012, 2013.
 
22) de Kretser DM, Bussard JJ, Okuma Y, et al. The role of activin, follistatin and inhibin in testicular physiology. Mol Cell Endocrinol 225 : 57-64, 2004.
 
23) Bilezikjian LM, Blount AL, Donaldson CJ, Vale WW. Pituitary actions of ligands of the TGF-beta family : activins and inhibins. Reproduction 132 : 207-215, 2006.
PubMed
24) Basaria S. Androgen abuse in athletes : detection and consequences. J Clin Endocrinol Metab 95 : 1533-1543, 2010.
PubMed
25) van Amsterdam J, Opperhuizen A, Hartgens F. Adverse health effects of anabolic-androgenic steroids. Regul Toxicol Pharmacol 57 : 117-123, 2010.
PubMed
26) Rahnema CD, Lipshultz LI, Crosnoe LE, et al. Anabolic steroid-induced hypogonadism : diagnosis and treatment. Fertil Steril 101 : 1271-1279, 2014.
PubMed
27) Virtanen HE, Bjerknes RB, Cortes D, et al. Cryptorchidism : classification, prevalence and long-term consequences. Acta Paediatr 96 : 611-616, 2007.
 
28) Grumbach MM. A window of opportunity : the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 90 : 3122-3127, 2005.
PubMed
29) Main KM, Schmidt IM, Skakkebaek NE. A possible role for reproductive hormones in newborn boys : progressive hypogonadism without the postnatal testosterone peak. J Clin Endocrinol Metab 85 : 4905-4907, 2000.
 
30) Hughes IA, Acerici CL. Factors controlling testis descent. Eur J Endocrinol 159 : S75-82, 2008.
 
31) Foresta C, Zuccarello D, Garolla A, Ferlin A. Role of hormones, genes, and environment in human cryptorchidism. Endocr Rev 29 : 560-580, 2008.
PubMed
32) Atkinson PM, Epstein MT, Rippon AE. Plasma gonadotropins and androgens in surgically treated cryptorchid patients. J Paediatr Surg 10 : 27-33, 1975.
 
33) Lee PA, Coughlin MT. Leydig cell function after cryptorchidism : evidence of the beneficial result of early surgery. J Urol 167 : 1824-1827, 2002.
PubMed
34) Harrington J, Palmert MR. Clinical review : Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism : critical appraisal of available diagnostic tests. J Clin Endocrinol Metab 97 : 3056-3067, 2012.
PubMed
35) Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86 : 724-731, 2001.
PubMed
36) Miraoui H, Dwyer AA, Sykiotis GP, et al. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet 92 : 725-743, 2013.
PubMed
37) Hardelin J-P, Dode C. The complex genetics of Kallmann syndrome : KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev 2 : 181-193, 2008.
PubMed
38) Kalyani RR, Gavini S, Dobs AS. Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am 36 : 333-348, 2007.
PubMed
39) Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol 152 : 501-513, 2005.
PubMed
40) Matthiesson KL, McLachlan RI, O'Donnell L, et al. The relative roles of follicle-stimulating hormone and luteinizing hormone in maintaining spermatogonial maturation and spermiation in normal men. J Clin Endocrinol Metab 91 : 3962-3969, 2006.
 
41) Page ST, Kalhorn TF, Bremner WJ, et al. Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment. J Androl 28 : 734-741, 2007.
PubMed
42) Roth MY, Page ST, Lin K, et al. Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency. J Clin Endocrinol Metab 95 : 3806-3813, 2010.
PubMed
43) Pitteloud N, Hayes FJ, Dwyer A, et al. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87 : 4128-4136, 2002.
PubMed
44) Ley SB, Leonard JM. Male hypogonadotropic hypogonadism : factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogeneous androgens. J Clin Endocrinol Metab 61 : 746-752, 1985.
PubMed
45) Pitteloud N, Dwyer A. Hormonal control of spermatogenesis in men : therapeutic aspects in hypogonadotropic hypogonadism. Ann Endocrinol (Paris) 75 : 98-100, 2014.
PubMed
46) Dwyer AA, Sykiotis GP, Hayes FJ, et al. Trial of recombinant folliclestimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 98 : E1790-1795, 2013.
PubMed
47) Matsumoto AM, Snyder PJ, Bhasin S, et al. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa ; GOANL-f) : long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril 92 : 979-990, 2009.
PubMed
48) Wang C, Alexander G, Berman N, et al. Testosterone replacement therapy improves mood in hypogonadal men : a clinical research center study. J Clin Endoclinol Metab 81 : 3578-3583, 1996.
 
49) Schulte-Beerbuhl M, Nieschlag E. Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum dihydrotestosterone after injection of testosterone enanthate of testosterone cypionate. Fertil Steril 33 : 201-203, 1980.
PubMed
50) Snyder PJ, Lawrence DA. Treatment of male hypogonadism with testosterone enantate. J Clin Endocrinol Metab 51 : 1335-1339, 1980.
PubMed
51) Wang C, Harnett M, Dobs AS, Swerdloff RS. Pharmacokinetics and safety of long-acting testosterone undecanoate injection in hypogonadal men : an 84-week phase III clinical trial. J Androl 31 : 457-465, 2010.
PubMed
52) Amory JK, Matsumoto AM. The therapeutic potential of testosterone patches. Expert Opin Investig Drugs 7 : 1977-1985, 1998.
PubMed
53) Wang C, Shwerdloff RS, Iranmanesh A, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85 : 2839-2853, 2000.
 
54) Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 363 : 109-122, 2010.
PubMed
55) Kallmann FJ, Schoenfeld WA, Barrera SE. The genetic aspect of primary eunuchoidism. Am J Ment Defic 48 : 203-236, 1944.
 
56) Schwanzel-Fukuda M, Pfaff DW. Origin of luteinizing hormone-releasing hormone neurons. Nature 338 : 161-164, 1989.
PubMed
57) Wierman ME, Kiseljak-Vassiliades K, Tobet S. Gonadotropin-releasing hormone (GnRH) neuron migration : initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Front Neuroendocrinol 32 : 43-52, 2011.
PubMed
58) Izumi Y, Tatsumi K, Okamoto S, et al. A novel mutation of the KAL1 gene in Kallmann syndrome. Endocr J 46 : 651-658, 1999.
PubMed
59) Matsuo T, Okamoto S, Izmumi Y, et al. A novel mutation of the KAL1 gene in monozygotic twins with Kallmann syndrome. Eur J Endocrinol 143 : 783-787, 2000.
 
60) Kaplan JD, Bernstein JA, Kwan A, et al. Clues to an early diagnosis of Kallmann syndrome. Am J Med Genet A 152A : 2796-2801, 2010.
 
61) Brioude F, Bouligand J, Trabado S, et al. Non-syndromic congenital hypogonadotropic hypogonadism : clinical presentation and genotypephenotype relationships. Eur J Endocrinol 162 : 835-851, 2010.
PubMed
62) 岡本新悟, 佐藤勝則, Mohammad Selim Reza. Kallmann症候群. Clin Neuroscience 39 : 616-617, 2021
 
63) 岡本新悟. Kallmann症候群. 浦上克哉ほか編 : 図説 神経機能解剖テキスト pp21-23. 文光社, 2017.
 
64) 岡本新悟, モハメッド・セリム・レザ, 榑松由佳子, ほか. Kallmann症候群のKAL1遺伝子解析と告知ならびに生涯ケア. 日本遺伝カウンセリング学会誌 26 : 49-54, 2005.
 
65) Okamoto S, Mimura M, Mochi T, et al. A male case of Kallmann's syndrome : fertility induced by gonadotropin (hCG/hMG) therapy. J Nara Med Ass 49 : 50-56, 1998.
 
66) Ishii T, Sasaki G, Hasegawa T, et al. Testosterone enanthate therapy is effective and independent of SRD5A2 and AR gene polymorphisms in boys with micropenis. J Urol 172 : 319-324, 2004.
PubMed
67) Groth KA, Skakkebaek A, Host C, et al. Clinical review : Klinefelter syndrome-a clinical update. J Clin Endocrinol Metab 98 : 20-30, 2013.
PubMed
68) Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E. Klinefelter's syndrome. Lancet 364 : 273-283, 2004.
PubMed
69) Aksglaede L, Skakkebaek NE, Almstrup K, Juul A. Clinical and biological parameters in 166 boys, adolescents and adults with nonmosaic Klinefelter syndrome : a Copenhagen experience. Acta Paediatr 100 : 793-806, 2011.
PubMed
70) 岡本新悟. クラインフェルター症候群に対する生涯ケアとテストステロン治療. 日本遺伝カウンセリング学会誌 25 : 75-80, 2004.
Medical*Online
71) 岡本新悟, 佐藤勝紀. クラインフェルター症候群 : 難治性疾患 (難病) を学ぶ. 遺伝子医学 10 : 115-122, 2020.
 
72) Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363 : 123-135, 2010.
 
73) Kaufmann JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26 : 833-876, 2005.
 
74) Corona G, Rastrelli G, Maggi M. Diagnosis and treatment of late-onset hypogonadism : systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab 27 : 557-579, 2013.
PubMed
75) Wylie K, Kenney G. Sexual dysfunction and the ageing male. Maturitas 65 : 23-27, 2010.
PubMed
76) Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men : a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 95 : 639-650, 2010.
 

参考資料

P.221 掲載の参考文献
1) Shiomo Melted (Author), et al. Williams Textbook of Endocrinology : 13th Edition. Elsevier. 2016.
 
2) Jameson JL (eds), et al. Endocrinology : Adult & Pediatric : 7th Edition. Elsevier. 2016.
 
3) Alexander S, Kauffman,Jeremy T Smith : Kisspeptin Signaling in Reproductive Biology. Springer. 2013.
 
4) 岡本新悟 : 成長障害を伴う内分泌疾患のスクリーニング法 : WHAMES法 (第II版). 奈良県発育異常研究会, 2012.
 
5) 岡本新悟, 脳腫瘍術後の下垂体機能低下症の治療 (第V版). 奈良県発育異常研究会, 2016.
 
6) 岡本新悟 : 「バングラデシュへの道」岡本海外医療援助基金, 2011.
 
7) Mohammad Selin Reza, Shingo Okamoto : Your Dream is My Dream : Ten year walk of Okamoto Medical Center. 2019.
 

書評

最近チェックした商品履歴

Loading...